Digital Health Market Size To Reach $946.0 Billion By 2030

 

The global Digital Health Market size is anticipated to reach USD 946.0 billion by 2030 and it is projected to grow at a CAGR of 21.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth driven by various factors. These include the proliferation of smartphones, advancements in internet connectivity, the development of IT infrastructure, increasing healthcare IT expenditures, overburdened healthcare facilities, a growing shortage of healthcare providers, rising demand for remote patient monitoring services, escalating medical costs, improved accessibility of virtual care services, and the increasing prevalence of chronic diseases. This growth is further propelled by the ongoing trend of digitalization in healthcare. This trend finds support in expanding public-private partnerships, emerging startups in the healthcare sector, and favorable initiatives undertaken by governments to promote digital health solutions.

Digital health encompasses diverse technologies such as telehealth services, health information technology, and mobile health (mHealth) to enhance communication within healthcare systems, fostering improved interactions between doctors and patients. The relevance of digital health technology has grown significantly, especially during the COVID-19 pandemic. These contemporary solutions enhance the patient-doctor relationship and extend preventive disease strategies. Furthermore, they contribute to a shift in healthcare towards value-based treatment, amplifying the accessibility of health information for both patients and healthcare providers.

Furthermore, integrating wearable devices into healthcare reshapes how individuals manage their health. Wearables like fitness trackers and smartwatches enable continuous monitoring of vital signs, physical activity, and other health metrics. This real-time data empowers individuals to take a proactive role in their well-being and allows healthcare providers to offer personalized preventive care. Companies such as Apple and Fitbit exemplify the success of wearables in the digital health market, emphasizing the fusion of technology and health monitoring.

Many nations have adopted telemedicine, remote monitoring platforms, and telehealth services to enable physical interactions among physicians and the patient population. Therefore, digital health industry experienced a boost in terms of revenue in 2020-2021 and is expected to maintain an upward trajectory in the projected technology life cycle. For instance, MyDoc, a telehealth platform headquartered in Singapore, witnessed a 160% growth in daily active users in 2020. Government initiatives to promote global digitalization in the healthcare sector are playing a significant role in propelling the market’s growth. For instance, in the 2022 budget session, the Government of India launched a digital health ecosystem as part of the Ayushman Bharat Digital Health Mission (ABDM). In October 2021, the French government revealed plans to invest over USD 650 million to enhance its digital health infrastructure nationally.

The digital health industry is a dynamic space where both established entities and startups compete for prominence, driven by the prospect of improving healthcare accessibility, affordability, and outcomes. Tech and healthcare giants are making ventures into this industry, coexisting with emerging local startups that address specific regional needs, attracting global investment. The growth of AI-powered solutions for patient monitoring and personalized care is evident, with the increasing involvement of healthcare professionals in their development and adoption. Moreover, various players are actively adopting strategies such as mergers, acquisitions, collaboration, partnerships, and product launches to maintain a competitive edge. For instance, in July 2023, Epic Systems Corporation collaborated with Nuance Communications, Inc., a Microsoft Company, to develop the Nuance Dragon Ambient eXperience (DAX) Express solution, which expands access to care for patients and enhances healthcare outcomes. Additionally, in December 2022, Greenway Health, LLC. Launched the Greenway Engagement Model, a client engagement program, to strengthen the healthcare technology journey of its clients.

List of Key Players in Digital Health Market

• Telefónica S.A.
• Epic Systems Corporation
• QSI Management, LLC
• AT&T
• AirStrip Technologies
• Google, Inc.
• Hims & Hers Health, Inc.
• Orange
• Softserve
• Computer Programs and Systems, Inc.
• Vocera Communications
• IBM Corporation
• CISCO Systems, Inc.
• Apple Inc.
• Oracle Cerner
• Veradigm
• Mckesson Corporation
• Hims & Hers Health, Inc.
• Vodafone Group
• Qualcomm Technologies, Inc.
• Samsung Electronics Co., Ltd.

Request a free sample copy or view report summary: Digital Health Market Report

Digital Health Market Report Highlights

• Based on component, the services segment accounted for largest revenue share in 2023, owing to the growing demand for services, such as installation, staffing, training, maintenance, and other services
• Based on technology, the tele-healthcare segment led the market with the largest revenue share of 43.2% in 2023, due to increasing preference for remote patient monitoring services and shortage of healthcare professionals
• Based on the application, the diabetes segment led the market with the largest share of 24.3% in 2023 and is expected to register the fastest CAGR over the forecast period. The obesity segment is the second largest in applications of the digital health market
• Based on the end-use, the patient segment held the largest market share of 34.1% in 2023 and is expected to witness the fastest CAGR during the forecast period
• North America dominated the market with a revenue share of 38.2% in 2023 due to the rapidly developing healthcare IT infrastructure, emergence of startups, growing funding options, and improving technological literacy

Related Press Release@ Digital Health Industry Analysis

Digital Health Market Segmentation

Grand View Research has segmented the global digital health market based on technology, component, application, end-use, and region:

Digital Health Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Tele-healthcare
• Tele-care

• Activity Monitoring
• Remote Medication Management
• Tele-health
• LTC Monitoring
• Video Consultation
• mHealth
• Wearables & Connected Medical Devices
• Vital Sign Monitoring Devices

• Heart Rate Monitors
• Activity Monitors
• Electrocardiographs
• Pulse Oximeters
• Spirometers
• Blood Pressure Monitors
• Others
• Sleep Monitoring Devices
• Sleep trackers
• Wrist Actigraphs
• Polysomnographs
• Others
• Electrocardiographs Fetal & Obstetric Devices
• Neuromonitoring Devices
• Electroencephalographs
• Electromyographs
• Others
• mHealth Apps
• Medical Apps
• Women's Health

• Fitness & Nutrition
• Menstrual Health
• Pregnancy Tracking & Postpartum Care
• Menopause
• Disease Management
• Others
• Chronic Disease Management Apps
• Diabetes Management Apps
• Blood Pressure & ECG Monitoring Apps
• Mental Health Management Apps
• Cancer Management Apps
• Obesity Management Apps
• Other Chronic Disease Management Apps
• Personal Health Record Apps
• Medication Management Apps
• Diagnostic Apps
• Remote Monitoring Apps
• Others (Pill Reminder, Medical Reference, Professional Networking, Healthcare Education)
• Fitness Apps
• Services
• Monitoring Services
• Independent Aging Solutions
• Chronic Disease Management & Post-Acute Care Services
• Diagnosis Services
• Healthcare Systems Strengthening Services
• Others
• Digital Health Systems
• EHR
• E-prescribing Systems
• Healthcare Analytics

Digital Health Component Outlook (Revenue, USD Million, 2018 - 2030)

• Software
• Hardware
• Services

Digital Health Application Outlook (Revenue, USD Million, 2018 - 2030)

• Obesity
• Diabetes
• Cardiovascular
• Respiratory Diseases
• Others

Digital Health End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Patients
• Providers
• Payers
• Others

Digital Health Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Sweden
• Denmark
• Norway
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Singapore
• Latin America
• Brazil
• Mexico
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Life Science Analytics Market To Reach $16.3 Billion By 2030

The global Life Science Analytics Market size is expected to reach USD 16.3 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.6% from 2023 to 2030. The growing demand to enhance patient care experience and improve clinical outcomes while minimizing rising healthcare expenses is driving the adoption of analytical solutions in the life sciences market. Social media and improving internet connectivity are significantly impacting the demand for analytical solutions. Emerging trends of the digitalization of healthcare and the growing demand for personalized medicine are contributing to the adoption rates. Furthermore, the adoption of big data analytics and the emergence of advanced data mining techniques are bolstering market growth. 

The ongoing Covid-19 pandemic exposed the shortcomings of the existing, overburdened healthcare systems, thus driving the demand for analytical solutions. Key players are rapidly making technological advancements to overcome the existing limitations and identify new verticals for growth. For instance, Moderna implemented IBM analytical solutions integrated with cloud computing, artificial intelligence algorithms, and blockchain solutions to successfully roll out their Covid-19 vaccine program.

The services component segment dominated the market in 2022 owing to the growing trend of outsourcing individual or multi-package services in implementing analytical solutions. Life science organizations lack the required expertise and resources, which drives the outsourcing of services from third-party vendors or consulting firms, which positively impacts the growth of the services segment. The descriptive type of analytical solutions led the market in 2021 owing to the growing implementation of descriptive analysis on historic datasets to analyze the current business scenarios. The predictive type segment is expected to grow lucratively over the forecast period owing to the rising adoption of advanced analytics to predict future outcomes and trends.

The sales and marketing support application segment dominated the market in 2022 owing to the rapid adoption of analytical solutions in sales and marketing functionalities of life science organizations to enhance customer responsiveness and improve engagement to achieve higher sales productivity. The research and development application segment is expected to grow significantly owing to the implementation of analytical solutions in the drug discovery and development process and clinical trial management. The growing product pipeline of life science organizations is contributing to the growth of the research and development segment. The on-demand delivery segment led the market in 2021 and is expected to grow lucratively owing to the rising demand for cloud-deployed and web-hosted analytical solutions with higher ease of access from remotest locations.

The pharmaceutical end-user segment dominated the market in 2022 owing to the rising adoption rates of analytical solutions in improving drug discovery processes and enhancing the efficiency of clinical trials. The biotechnology end-user segment is expected to register the fastest growth rate over the forecast period owing to the adoption of analytical solutions in genome sequencing and analysis. In 2021, North America dominated the market owing to advanced digital literacy, adequate healthcare IT infrastructure, the presence of key players, and high economic development. Asia Pacific is expected to grow lucratively owing to the emergence of startups, favorable funding options, supportive government initiatives, growing healthcare IT expenditure, and the easy availability of high-skilled and low-cost personnel.

List of Key Players of Life Science Analytics Market

• Accenture
• Cognizant
• IBM
• Oracle
• SAS Institute, Inc.
• Wipro Limited
• IQVIA
• Take Solutions Limited

Request a free sample copy or view report summary: Life Science Analytics Market Report

Life Science Analytics Market Report Highlights

• The services component segment dominated the market in 2022 due to the lack of expertise and resources in life science organizations, which drives them to outsource these services
• The descriptive type segment led the market in 2022 owing to the rising adoption of descriptive analytics on historic datasets to understand the current business scenarios
• The sales and marketing support application segment captured the largest revenue share in 2022 owing to the rising adoption of analytical solutions in enhancing customer responsiveness and engagement to improve sales productivity
• The on-demand delivery segment dominated the market in 2022 owing to the growing demand for cloud-deployed and web-hosted analytical solutions
• By end-user, the pharmaceutical segment held the largest revenue share in 2022 owing to the rising adoption of analytical solutions in clinical trials management and growing product pipeline
• North America dominated the market in 2022 owing to the availability of adequate healthcare IT infrastructure and higher digital literacy

Life Science Analytics Market Segmentation

Grand View Research, has segmented the global life science analytics market on the basis of component, type, application, delivery, end-user, and region:

Life Science Analytics Component Outlook (Revenue, USD Million, 2018 - 2030)

• Software
• Services

Life Science Analytics Type Outlook (Revenue, USD Million, 2018 - 2030)

• Reporting
• Descriptive
• Predictive
• Prescriptive

Life Science Analytics Application Outlook (Revenue, USD Million, 2018 - 2030)

• Research and Development
• Sales and Marketing Support
• Regulatory Compliance
• Supply Chain Analytics
• Pharmacovigilance

Life Science Analytics Delivery Outlook (Revenue, USD Million, 2018 - 2030)

• On-demand
• On-premises

Life Science Analytics End User Outlook (Revenue, USD Million, 2018 - 2030)

• Medical Device
• Pharmaceutical
• Biotechnology
• Others

Life Science Analytics  Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Plasmid Purification Market Size To Reach $3.69 Billion By 2030

The global plasmid purification market size is anticipated to reach USD 3.69 billion by 2030 and is projected to grow at a CAGR of 11.60% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising acceptance of cell & gene therapy and growing demand for recombinant technology products are factors contributing to market growth. Moreover, technological advancements in plasmid purification further propel market growth.

Plasmids are crucial in gene therapy and genetic medicine. Their unique properties allow them to serve as effective vectors for delivering therapeutic genes into target cells. Plasmids function by introducing exogenous genes into specific cells to correct or replace defective genes responsible for diseases. Moreover, with the increasing acceptance and application of gene therapy for treating various diseases, there is a growing need for purified plasmid DNA. In gene therapy, plasmids serve as vectors for delivering therapeutic genes.

Researchers design plasmids to carry therapeutic genes, including normal copies of mutated genes, genes encoding proteins to combat disease, or RNA molecules like shRNA that can silence harmful genes. Plasmid purification is critical in the development and application of gene therapy. Contaminants such as chromosomal DNA, proteins, endotoxins, and residual bacterial components can interfere with the efficacy and safety of the therapeutic product. Thus, advancements in purification technologies enhance the yield and quality of plasmid DNA, facilitating the scalability of plasmid production, which is essential for meeting the increasing demands of gene therapy development.

The COVID-19 pandemic has significantly impacted the market growth. The increased demand for synthetic biology products, driven by the urgent need for COVID-19 vaccines and treatments, has accelerated research and development (R&D) in cloning technology. This surge in R&D activities in synthetic biology has led to increased funding and investment in companies involved in vaccine development, diagnostics, and therapeutic research. Moreover, despite the challenges posed by the pandemic, the market is expected to continue growing steadily due to the increasing adoption of novel technologies, the rising demand for gene therapies, and ongoing advancements in genetic engineering.

However, one of the primary concerns of the market is the ethical constraints related to the use of recombinant DNA technology is the misuse of gene cloning and synthesis technology in the creation of harmful pathogens through synthetic biology techniques to develop bioweapons. Improper handling or disposal of synthetic DNA and plasmids could lead to environmental contamination. Engineered organisms released into the environment could have ecological consequences.

List of Key Players in the Plasmid Purification Market

• Merck KGaA
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Takara Bio
• Promega Corporation
• Zymo Research
• MP BIOMEDICALS
• New England Biolabs
• MCLAB
• Applied Biological Materials Inc.

Request a free sample copy or view report summary: Plasmid Purification Market Report

Plasmid Purification Market Report Highlights

• The products segment led the market with the largest revenue share of 72.93% in 2023, as the use of specialized kits and reagents significantly enhances the efficiency, reliability, and quality of the purification process. Furthermore, the services segment is anticipated to experience at a significant CAGR of 12.58% from 2024 to 2030
• Based on grade, the molecular grade segment led the market with the largest revenue share of 58.42% in 2023, as these plasmids are engineered to be easily manipulated and modified, allowing researchers to make precise changes to the genetic material. The transfection grade segment is anticipated to grow at the fastest CAGR of 13.24% over the forecast period
• Based on application, the cloning & protein segment led the market with the largest revenue share of 48.76% in 2023, owing to the growing demand for genetically modified crops and organisms. Furthermore, the transfection & gene editing segment is expected to grow at the fastest CAGR over the forecast period.
• Based on end use, the academic & research institutes segment led the market with the largest revenue share of 40.12% in 2023, driven by their significant contribution to R&D to bring novel gene therapy treatments and engineered biotechnological products to market. Also, the contract research organizations segment is expected to expand at the fastest CAGR of 13.38% during the forecast period, due to their increasing adoption and investment in advanced research and manufacturing technologies
• North America dominated the market with the largest revenue share of 40.58% in 2023, owing to factors such as increasing investments in R&D activities, rising demand for personalized medicine, and advanced biotechnology research infrastructure

Plasmid Purification Market Segmentation

Grand View Research has segmented the global plasmid purification market based on product & service, grade, application, end-use, and region:

Plasmid Purification Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

• Products
• Instruments
• Kits & Reagents
• Services

Plasmid Purification Grade Outlook (Revenue, USD Million, 2018 - 2030)

• Molecular Grade
• Transfection Grade

Plasmid Purification Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cloning & Protein Expression
• Transfection & Gene Editing
• Others

Plasmid Purification End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Plasmid Purification Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE
• Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com